- Home
- CURR vs ME Comparison
CURR vs ME Comparison
Compare CURR & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURR
- ME
- Stock Information
- Founded
- CURR 2013
- ME 2006
- Country
- CURR Singapore
- ME United States
- Employees
- CURR N/A
- ME N/A
- Industry
- CURR Business Services
- ME Precision Instruments
- Sector
- CURR Consumer Discretionary
- ME Health Care
- Exchange
- CURR Nasdaq
- ME Nasdaq
- Market Cap
- CURR 89.8M
- ME 86.5M
- IPO Year
- CURR N/A
- ME N/A
- Fundamental
- Price
- CURR $1.53
- ME $3.44
- Analyst Decision
- CURR
- ME Hold
- Analyst Count
- CURR 0
- ME 1
- Target Price
- CURR N/A
- ME $9.40
- AVG Volume (30 Days)
- CURR 1.3M
- ME 260.2K
- Earning Date
- CURR 02-11-2025
- ME 02-05-2025
- Dividend Yield
- CURR N/A
- ME N/A
- EPS Growth
- CURR N/A
- ME N/A
- EPS
- CURR N/A
- ME N/A
- Revenue
- CURR $48,723,898.00
- ME $193,260,000.00
- Revenue This Year
- CURR N/A
- ME $21.93
- Revenue Next Year
- CURR N/A
- ME $17.31
- P/E Ratio
- CURR N/A
- ME N/A
- Revenue Growth
- CURR N/A
- ME N/A
- 52 Week Low
- CURR $1.19
- ME $2.66
- 52 Week High
- CURR $5.74
- ME $19.20
- Technical
- Relative Strength Index (RSI)
- CURR N/A
- ME 48.82
- Support Level
- CURR N/A
- ME $3.15
- Resistance Level
- CURR N/A
- ME $3.48
- Average True Range (ATR)
- CURR 0.00
- ME 0.24
- MACD
- CURR 0.00
- ME 0.05
- Stochastic Oscillator
- CURR 0.00
- ME 61.76
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech banking platform for e-wallets, financial institutions and merchants worldwide, delivering frictionless interoperable real-time fund transfers and instant messaging.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.